We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA: PhRMA Study on Authorized Generics "Filled With Errors"
GPhA: PhRMA Study on Authorized Generics "Filled With Errors"
August 8, 2006
The Generic Pharmaceutical Association (GPhA) issued a study July 31 that shows the long-term effect of allowing brand drug companies to launch an authorized generic during a generic firm's 180-day exclusivity period will be decreased competition and reduced access to cheaper drugs.